|
⚲
|
| Keyboard |
| David Scheer | |
|---|---|
| Firm | |
| Address | 512 East Township Line Road 4 Valley Square Blue Bell, PA 19422 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Thirdlaw Molecular Inc | 021-560187 | Director | 5.5 M of 5.5 M |
||
| Adela Inc | 021-550950 | Executive Officer | 25.4 M of 27.0 M |
||
| Adela Inc | 021-505329 | Executive Officer | 3.3 M of 3.3 M |
||
| Adela Inc | 021-505327 | Executive Officer | 1.2 M of 1.2 M |
||
| Adela Inc | 021-489534 | Executive Officer | 48.5 M of 49.3 M |
||
| Thyron Pharmaceuticals Inc | 021-444202 | Executive Officer | 0.5 M of 1.0 M |
||
| Revelar Biotherapeutics Inc | 021-434641 | Director | 1.0 M of 1.0 M |
||
| Revelar Biotherapeutics Inc | 021-421689 | Director | 17.5 M of 22.5 M |
||
| Refactor Health Inc | 021-414714 | Director | 0.3 M of 0.3 M |
||
| Refactor Health Inc | 021-414730 | Director | 0.3 M of 0.3 M |
||
| Dnamx Inc | 021-394218 | Director | 30.0 M of 60.0 M |
||
| Planit Impact Inc | 021-309089 | Executive Officer | 0.5 M | ||
| Tengion Inc | 021-200927 | Director | 74.3 M of 74.3 M |
||
| Tengion Inc | 021-185316 | Director | 15.0 M of 15.0 M |
||
| Tengion Inc | 021-156826 | Director | 31.4 M of 31.4 M |
||
| Achillion Pharmaceuticals Inc | 021-146800 | Director | 50.1 M of 50.1 M |
||
| Axerion Therapeutics Inc | 021-140586 | Director | 0.8 M of 0.8 M |
||
| Optherion Inc | 021-102365 | Director | 5.0 M of 9.5 M |
||
| Aegerion Pharmaceuticals Inc | 021-80824 | Director | 18.3 M of 19.8 M |
||